Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer

por Denys, Hannelore, Martinez-Mena, Corina L., Martens, Marc T., D’Hondt, Randal G., Graas, Marie-Pascale L., Evron, Ella, Fried, Georgeta, Ben-Baruch, Noa E., Vulsteke, Christof, Van Steenberghe, Mona M.
Publicado 2020